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Abstract
Telocytes (TC) are typically defined as cells with telopodes by their ultrastructural features. Their presence was reported in the interstitium of
various organs in vertebrates, including humans. However, no study has yet described the presence of TC in the human eye and in particular,
within the stromal compartment of the cornea. To address this issue, samples of normal and pathologic (keratoconic) human corneas were
tested by immunohistochemistry for CD34, platelet-derived growth factor receptor a (PDGFRa) and c-kit/CD117 or examined by transmission
electron microscopy. We found that TC coexpressing CD34 and PDGFRa were distributed throughout the whole normal corneal stroma with dif-
ferent TC subtypes being distinguishable on the basis of the expression of the stemness marker c-kit (i.e. c-kit-positive and c-kit-negative TC
subpopulations). Transmission electron microscopy examination confirmed the existence of spindle-shaped and bipolar TC typically displaying
two long and thin moniliform telopodes establishing intercellular contacts formed by gap junctions. Keratoconic corneas were characterized by
ultrastructural damages and patchy loss of TC with an almost complete depletion of the c-kit-positive TC subpopulation. We propose that TC
may contribute to the maintenance of corneal stromal homoeostasis and that, in particular, the c-kit-positive TC subtype might have stemness
capacity participating in corneal regeneration and repair processes. Further studies are needed to clarify the differential roles of corneal TC
subtypes as well as the possible therapeutic applications of TC in degenerative corneal disorders such as keratoconus.
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Introduction
The cornea is an optically clear tissue that forms the front ocular
surface and accounts for nearly two-thirds of the eye refractive
power [1]. It consists of three cell layers: an outer epithelium, a
middle avascular stromal layer formed by a collagen-rich extracellu-
lar matrix (ECM) interspersed with interstitial cells and an inner
layer of endothelial cells. The aforementioned layers are bordered
by two membranes, namely the Bowman’s membrane between the
epithelial layer and the stromal layer, and the Descemet’s mem-
brane between the stromal layer and the endothelium [2, 3]. Cornea
must be transparent and maintain a smooth and stable curvature
as it contributes to the major part of the focusing power of the
eye. Corneal transparency is conferred by the highly organized ECM
of the corneal stroma which represents more than 90% of the cor-
neal thickness. In the corneal stroma, parallel bundles of collagen
fibres are tightly packed in lamellae lying parallel to the corneal
surface [2].
Corneal stromal cells, generally referred to as keratocytes, are
interspersed between the collagen lamellae and are believed to play
an important role in the preservation of corneal transparency and
mechanical stability through the synthesis and/or maintenance of the
ECM [4]. Keratocytes have been described as cells displaying a den-
dritic-like morphology characterized by a compact cell body with
numerous cytoplasmic lamellipodia which establish intercellular junc-
tions forming a three-dimensional network [4, 5]. As far as keratocyte
immunophenotype is concerned, these cells are commonly identified
by immunohistochemistry for the CD34 antigen [6–8]. Moreover,
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these cells are known to undergo morphological and quantitative
changes in corneal pathologies such as in keratoconus, a non-inflam-
matory ectatic disorder characterized by a reduction in keratocyte
density mainly due to increased apoptotic cell death [6, 7, 9].
A new type of interstitial cells, named telocytes (TC), has been
recently described in the stromal compartment of many organs in
vertebrates including humans [10–22]. Moreover, this peculiar stro-
mal cell type is being increasingly implicated in a wide range of
pathologies with potential applications in regenerative medicine [23–
36]. Telocyte possess unique ultrastructural features consisting of a
small cell body and extremely long and thin prolongations, termed tel-
opodes, displaying a moniliform aspect characterized by the alterna-
tion of thin segments (called podomers) and small dilated regions
(called podoms) accommodating mitochondria, endoplasmic reticu-
lum cisternae and caveolae [11, 12, 37]. Telopodes are typically orga-
nized in a three-dimensional network which comprises either
homocellular junctions between TC or heterocellular communications
between TC and other cell types [11, 12, 38, 39]. Moreover, TC are
believed to participate in intercellular signalling through the release of
different types of extracellular vesicles, such as exosomes, ecto-
somes and multivesicular cargos [12, 40–42]. Although TC do not
possess a unique antigenic profile, a combination of CD34 and plate-
let-derived growth factor receptor a (PDGFRa) is currently consid-
ered the most reliable marker for their immunohistochemical
identification [12]. Indeed, coexpression of CD34 and PDGFRa has
been widely observed in TC from different human organs [12, 43,
44]. It also appears that the TC immunophenotype may vary among
systems and that different TC subtypes likely playing differential roles
may coexist within the same organ [45–49]. For instance, TC may
express either CD34, PDGFRa or c-kit/CD117 in some human organs,
such as the heart, while they are CD34+/PDGFRa+ and c-kit-negative
in others, such as the gastrointestinal tract [25, 43–45, 47].
To the best of our knowledge, to date, no study has described the
possible presence of TC within the stromal compartment of the human
cornea. Considering the striking similarities between some of the mor-
phological and immunophenotypical features of TC and those described
for the so-called corneal keratocytes [1, 4–6], here we were prompted
to investigate whether TC may represent a cellular component of the
human corneal stroma. To this aim, we carried out a series of immuno-
histochemical and ultrastructural studies on human corneal specimens,
including a comparison between normal and keratoconic corneas.
Materials and methods
Human corneal specimens
The study was carried out on six normal human corneas from Eye Bank
and six human corneal buttons from patients with keratoconus without
subepithelial scarring removed during penetrating keratoplasty, as
described elsewhere [6]. All the patients signed a written informed con-
sent form, and the study was carried out in accordance with the Decla-
ration of Helsinki and approved by the Institutional Review Board.
Central corneal buttons of similar diameter were analysed. Immediately
after removal, the corneal buttons were cut in small pieces which were
processed for light, fluorescence and transmission electron microscopy.
Immunoperoxidase-based immunohistochemistry
Immunohistochemical studies were performed on deparaffinized and
rehydrated corneal sections (5 lm thick). Corneal tissue sections were
boiled for 10 min. in sodium citrate buffer (10 mM, pH 6.0) for antigen
retrieval and treated with 3% hydrogen peroxide solution for 15 min. at
room temperature to block endogenous peroxidase activity. Sections were
then washed and incubated with Ultra V block (UltraVision Large Volume
Detection System Anti-Polyvalent, HRP, catalogue number TP-125-HL;
Lab Vision, Fremont, CA, USA) for 10 min. at room temperature according
to the manufacturer’s protocol. After blocking non-specific site binding,
slides were incubated overnight at 4°C with mouse monoclonal anti-
human CD34 antibody (1:50 dilution; clone QBEnd-10, catalogue number
M7165; Dako, Glostrup, Denmark). The day after, tissue sections were
washed three times in PBS and subsequently incubated with biotinylated
secondary antibodies (UltraVision Large Volume Detection System Anti-
Polyvalent, HRP; Lab Vision) for 10 min. at room temperature. The slides
were then washed three times in PBS and incubated with streptavidin per-
oxidase (UltraVision Large Volume Detection System Anti-Polyvalent,
HRP; Lab Vision) for 10 min. at room temperature. Immunoreactivity was
developed using 3,30-diaminobenzidine tetrahydrochloride as chromogen
(Sigma-Aldrich, St. Louis, MO, USA). Corneal sections were finally coun-
terstained with Mayer’s haematoxylin (Bio-Optica, Milan, Italy) and
observed under a Leica DM4000 B microscope equipped with fully auto-
mated transmitted light axes (Leica Microsystems, Mannheim, Germany).
Sections not exposed to primary antibodies or incubated with isotype-
matched and concentration-matched non-immune mouse IgG (Sigma-
Aldrich) were included as negative controls for antibody specificity. Light
microscopy images were captured with a Leica DFC310 FX 1.4-megapixel
digital colour camera equipped with the Leica software application suite
LAS V3.8 (Leica Microsystems).
Immunofluorescence staining
Double immunofluorescence staining combining CD34 either with
PDGFRa or c-kit/CD117 was performed according to previously pub-
lished studies [31, 32, 43]. Paraffin-embedded corneal tissue sections
(5 lm thick) were deparaffinized, rehydrated and boiled for 10 min. in
sodium citrate buffer (10 mM, pH 6.0). Sections were washed in PBS,
incubated in 2 mg/ml glycine for 10 min. to quench autofluorescence
caused by free aldehydes and then blocked for 1 hr at room tempera-
ture with 1% bovine serum albumin (BSA) in PBS. The sections were
then incubated overnight at 4°C with the following primary antibodies
diluted in PBS with 1% BSA: mouse monoclonal anti-human CD34
(1:50 dilution; clone QBEnd-10, catalogue number M7165; Dako), goat
polyclonal anti-human PDGFRa (1:100 dilution; catalogue number AF-
307-NA; R&D Systems, Minneapolis, MN, USA) and rabbit polyclonal
anti-c-kit/CD117 (1:200 dilution; catalogue number A4502; Dako). The
day after, the slides were washed three times in PBS and incubated for
45 min. at room temperature in the dark with Alexa Fluor-568-conju-
gated donkey anti-mouse IgG, Alexa Fluor-488-conjugated donkey anti-
goat IgG or Alexa Fluor-488-conjugated goat anti-rabbit IgG (Invitrogen,
San Diego, CA, USA) diluted 1:200 in PBS with 1% BSA, as secondary
antibodies. Double immunofluorescence staining was performed by mix-
ing mouse and rabbit or goat primary antibodies and subsequently
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mixing appropriate fluorochrome-conjugated secondary antibodies. Irrel-
evant isotype-matched and concentration-matched mouse, rabbit and
goat IgG (Sigma-Aldrich) were used as negative controls. Cross-reactiv-
ity of secondary antibodies was tested in control experiments in which
primary antibodies were omitted. Nuclei were counterstained with 40,6-
diamidino-2-phenylindole (DAPI; Chemicon International, Temecula, CA,
USA). Corneal sections were then mounted with an antifade aqueous
mounting medium (Biomeda Gel Mount; Electron Microscopy Sciences,
Foster City, CA, USA) and examined with a Leica DM4000 B microscope
equipped with fully automated fluorescence axes (Leica Microsystems).
Fluorescence images were captured with a Leica DFC310 FX 1.4-mega-
pixel digital colour camera equipped with the Leica software application
suite LAS V3.8 (Leica Microsystems).
Quantitative analysis
Quantitative analysis of TC was performed on corneal tissue sections
immunostained with the mouse monoclonal anti-CD34 antibody and the
rabbit polyclonal anti-c-kit/CD117 antibody and counterstained with
DAPI for nuclei. CD34-positive and c-kit-positive TC were counted in 10
randomly chosen microscopic high-power fields (hpf; 409 original
magnification) per sample. Only the cells with well-defined nuclei were
counted. Counting was performed by two independent observers who
were blinded with regard to the sample classification. The final result
was the mean of the two different observations for each sample.
Transmission electron microscopy
For transmission electron microscopy, human corneal specimens were
divided into small fragments and fixed in 4% cacodylate-buffered glu-
taraldehyde (pH 7.4) at room temperature. Then, the specimens were
rinsed in a cacodylate-buffered solution supplemented with sucrose,
post-fixed in 1% osmium tetroxide (Electron Microscopy Sciences),
dehydrated with graded alcohol series, transferred to propylene oxide
and embedded in epoxy resin (Epon 812). Semithin sections (2 lm
thick) were cut with a RMC MT-X ultramicrotome (EMME3, Milan, Italy)
and stained with a solution of toluidine blue in 0.1 M borate buffer, and
then observed under a light microscope. Ultrathin sections (~70 nm
thick) of the selected areas were obtained with the same ultramicrotome
using a diamond knife and stained with an alcoholic solution of uranyl
acetate, followed by an alkaline solution of bismuth subnitrate. Ultrathin
sections were examined and photographed under a JEOL JEM-1010
electron microscope (Jeol, Tokyo, Japan) equipped with a MegaView III
high-resolution digital camera and imaging software (Jeol). Measure-
ments of telopode length and width were performed on at least 20 ran-
domly selected structures per corneal sample. All measurements were
carried out on captured transmission electron microscopy photomicro-
graphs employing the ImageJ software (NIH, Bethesda, MD, USA).
Results expressed in pixels were converted to their equivalent in lm or
nm by the Set Scale function of ImageJ using the scale bar printed on
the photomicrograph as reference.
Statistical analysis
All data are represented as the mean  S.D. Statistical analysis was
performed using the Student’s t-test for independent samples. P < 0.05
was considered statistically significant. The SPSS software for Windows
Version 12.0 (SPSS, Chicago, IL, USA) was used.
Results
Normal human cornea
In normal human corneas, immunoperoxidase-based immunohisto-
chemistry revealed the presence of numerous CD34-positive cells
throughout the whole thickness of the corneal stroma (Fig. 1A–C).
These stromal cells were arranged mainly parallel to the corneal sur-
face and were interspersed between the ECM lamellae (Fig. 1A). In
particular, CD34-positive stromal cells were spindle-shaped and usu-
ally displayed a small oval body and two long and thin varicose pro-
longations (Fig. 1B and C). Indeed, their cytoplasmic processes
typically presented slender segments alternated with small dilated
regions (Fig. 1B and C).
We further characterized the immunophenotype of these stromal
cells by CD34/PDGFRa double immunofluorescence staining. Double
immunolabelling analysis showed colocalization of CD34 and
PDGFRa in all corneal stromal cells either in the anterior stroma
(Fig. 1D–F) or in the deeper stromal layer (Fig. 1G–I). As displayed in
Figure 1D–F, in the anterior stroma, some CD34+/PDGFRa+ cells were
located close to the border of the Bowman’s membrane. In the whole
corneal stroma, these CD34+/PDGFRa+ cells appeared orderly
arranged parallel to the corneal surface (Fig. 1D–I). At higher magnifi-
cation, CD34+/PDGFRa+ corneal stromal cells clearly exhibited long
prolongations with a moniliform appearance (Fig. 1G–I).
Double immunostaining for CD34 and c-kit was also performed
on human corneal specimens. As shown in Figure 1J–L, numerous
CD34-positive stromal cells displayed c-kit immunoreactivity. In par-
ticular, CD34+/c-kit+ cells were identified either in the subepithelial
stroma or in the deeper stroma (Fig. 1J–L).
Next, we carried out transmission electron microscopy to evaluate
in depth the ultrastructural features of these corneal stromal cells. As
displayed in Figure 2, corneal stromal cells were embedded in the col-
lagen matrix and appeared as spindle-shaped bipolar cells character-
ized by a slender body and usually two very long and thin cytoplasmic
prolongations establishing intercellular junctions (Fig. 2A–C). These
cells lacked a basal lamina and had a scarce cytoplasm surrounding
the nucleus with few mitochondria and cisternae of endoplasmic
reticulum and a small Golgi apparatus (Fig. 2B and C). Their collagen-
embedded cellular processes were characteristically very long (up to
~50 lm; 34.6  8.3 lm) and thin, with an uneven calibre and a
moniliform aspect due to the alternation of thin segments
(89.3  47.2 nm) and dilated portions (274.5  92.4 nm) which
contained mitochondria, endoplasmic reticulum cisternae and caveo-
lae (Fig. 2D and E). Moreover, gap junctions, a specialized intercellu-
lar connection, were typically observed between the prolongations of
corneal stromal cells (Fig. 2E).
Collectively, our findings provide evidence that stromal cells with
typical ultrastructural features (i.e. cells with telopodes characterized
by the alternation of podomers and podoms) and immunophenotypes
3604 ª 2017 The Authors.





Fig. 1 Representative light and fluorescence microscopy photomicrographs of normal human corneal sections. (A–C) CD34 immunoperoxidase-
based immunohistochemistry with haematoxylin counterstain. (A) CD34-positive stromal cells are orderly arranged and parallel to the corneal sur-
face. (B and C) At higher magnification, the CD34-positive stromal cells appear as spindle-shaped cells with a small oval body and typically two long
and thin moniliform cell processes characterized by the alternation of slender segments (arrows) and knobs/dilations (arrowheads) along their
length. (D–I) Double immunofluorescence labelling for CD34 (red) and PDGFRa (green) with DAPI (blue) counterstain for nuclei. Colocalization of
CD34 and PDGFRa in stromal cells gives rise to yellow staining either in the anterior corneal stroma (D–F) or in the deeper corneal stromal layer
(G–I). CD34+/PDGFRa+ stromal cells display cell morphologies very evocative for telocytes: a small cell body with very long prolongations (telo-
podes) characterized by a moniliform silhouette with the alternation of podoms (arrowheads) and podomers (arrows). (J–L) Double immunofluores-
cence labelling for CD34 (red) and c-kit (green) with DAPI (blue) counterstain for nuclei. Either in the subepithelial corneal stroma or in the deeper
stromal layer, numerous CD34-positive stromal cells coexpress c-kit. Inset: Higher magnification view of CD34+/c-kit+ corneal stromal cells. Scale
bar: 50 lm (A, D–F and J–L), 25 lm (B, C and G–I).
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Fig. 2 Representative transmission electron microscopy photomicrographs of normal human corneal ultrathin sections. Corneal stromal cells with
the typical ultrastructural features of telocytes are observed. (A) Two telocytes show a small cell body and very long and thin processes (telopodes)
that are collagen-embedded and connected with intercellular junctions. (B and C) Corneal telocytes lack a basal lamina and have a scarce cytoplasm
surrounding the nucleus with few mitochondria and cisternae of endoplasmic reticulum and a small Golgi apparatus. (B–E) Telopodes display a
moniliform aspect due to the alternation of thin segments (podomers) and dilated cistern-like portions (podoms) oval or triangular in shape. (D and
E) Podoms contain mitochondria, endoplasmic reticulum cisternae and caveolae. (E) Telopodes originating from different telocytes establish gap
junctions (arrowhead) at the site of contact. Right inset: Higher magnification of a gap junction between two telopodes. Left inset: Higher magnifica-
tion of a podom accommodating mitochondria, rough endoplasmic reticulum and caveolae. A shed vesicle is visible near the telopode. TC: telocyte;
Tp: telopode; c: caveola; m: mitochondrion; rER: rough endoplasmic reticulum; v: vesicle. Scale bar: 6 lm (A), 2 lm (B and C), 1 lm (D and E).
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of TC are present in the human cornea. In addition, our immunohisto-
chemical data support the notion that all human corneal TC are
CD34+/PDGFRa+ and that different TC subtypes may coexist within
the corneal stroma, namely c-kit-positive and c-kit-negative subpopu-
lations.
Keratoconic human cornea
A striking reduction in CD34-positive stromal cells (hereafter referred
to as TC) was found in keratoconic corneas compared with normal
corneas (Fig. 3A–C). In particular, in keratoconus TC were unevenly
distributed throughout the corneal stroma, with a loss of CD34
immunoreactivity mostly evident in the anterior stroma (Fig. 3B).
Indeed, quantitative analysis revealed that the number of CD34-posi-
tive TC/hpf was significantly reduced in keratoconic corneas com-
pared with healthy control corneas (21.4  3.9 versus 45.2  5.4,
P < 0.001; Fig. 3C). These findings were further confirmed by CD34/
PDGFRa double immunofluorescence labelling (Fig. 3D–I). Indeed,
while in control corneas CD34+/PDGFRa+ TC were typically found in
the whole corneal stroma (Fig. 3D–F), in keratoconus a patchy loss of
CD34/PDGFRa immunoreactivity was observed mainly in the subep-
ithelial part of the stroma (Fig. 3G–I). Moreover, double staining for
CD34 and c-kit either confirmed the severe reduction in CD34-positive
TC or revealed an almost complete loss of c-kit immunoreactivity in
keratoconic corneas compared with normal corneas (Fig. 3J–L). In
fact, as shown in Figure 3L, the number of c-kit-positive TC/hpf was
significantly decreased in keratoconus compared with controls
(3.1  3.8 versus 24.5  2.3, P < 0.001).
Finally, we performed a comparative ultrastructural analysis between
keratoconic and normal corneas under transmission electron micro-
scopy (Fig. 4A–E). At variance with normal corneas, in keratoconus, the
majority of TC exhibited ultrastructural abnormalities such as a dark
cytoplasm containing numerous swollen mitochondria, loss of
organelles and cytoplasmic vacuolization (Fig. 4A–C). As displayed in
Figure 4D, some keratoconic TC still showed a preserved ultrastructural
morphology. Furthermore, in keratoconus the severity of ultrastructural
damages was variable among TC (Fig. 4B, C and E). Indeed, some TC
were even characterized by severe degenerative processes including
shrinkage and shortening of the telopodes, as well as apoptotic chro-
matin condensation and nuclear fragmentation (Fig. 4E). Of note, the
most severely damaged TC appeared often embedded in a matrix with
irregularly distributed collagen bundles (Fig. 4C and E).
Discussion
In the last years, numerous studies have shown the existence of a
novel and peculiar stromal cell type, the TC, in many different organs
and tissues of vertebrates including laboratory mammals and humans
[10–22]. As far as the ocular system is concerned, a recent report
described the presence of TC in the limbus, sclera and uvea of the
mouse eye [50]. However, to the best of our knowledge, no study has
yet described the presence of TC in the human eye and in particular,
within the stromal compartment of the cornea.
Here, for the first time, we provide direct evidence for the exis-
tence of TC in human cornea by an integrated immunohistochemical
and transmission electron microscopy approach. In fact, according to
recent literature data [11, 12, 37, 43, 45, 46], corneal TC were mainly
recognizable for their typical ultrastructural features (i.e. cells with tel-
opodes characterized by the alternation of podomers and podoms)
and were immunophenotypically characterized by double
immunopositivity for the CD34 and PDGFRa antigens. Noteworthy,
the length and width of the telopodes of human corneal TC were con-
sistent with those previously reported for TC in the limbus, sclera and
uvea of the mouse eye [50]. Moreover, our immunohistochemical
findings are in agreement with the view that, although the immuno-
histochemical profile of TC may vary among different organs and
even in the same organ examined [45, 46], at present, CD34/PDGFRa
double labelling should be regarded as one of the best marker combi-
nation for TC identification under light and fluorescence microscopy
[12]. Of note, CD34 has been validated as marker of human corneal
stromal cells (generally termed keratocytes) in previous studies [6–
8]. Thus, taken together, our present findings provide evidence that
human corneal stromal cells/keratocytes possess unique ultrastruc-
tural features and immunophenotypes which allow the ‘diagnosis’ of
TC.
Interestingly, our immunohistochemical results not only indicate
that all human corneal TC are CD34+/PDGFRa+ but also that different
TC subtypes coexist within the corneal stroma according to the coex-
pression of the stemness marker c-kit/CD117 (i.e. c-kit-positive and
c-kit-negative TC subpopulations). Consistent with these findings,
previous reports have shown that TC subpopulations sharing the
same distinctive ultrastructural features but expressing different
immunophenotypical markers may likely play distinct and/or region-
specific roles in various organs, such as in the urinary bladder and in
the cardiac striated muscle [45–48]. Moreover, the presence of differ-
ent subpopulations of corneal stromal cells (e.g. keratoblasts, kerato-
cytes and quiescent keratocytes), including cells with stemness
features, has previously been suggested in the cornea [2, 51]. On the
basis of our data, we speculate that in human cornea, the c-kit-posi-
tive and c-kit-negative TC subpopulations might play differential roles.
In particular, we propose that the c-kit-positive TC might preferen-
tially be involved in corneal regenerative processes presumably acting
as precursor cells. This hypothesis is further supported by our
immunohistochemical data showing that the c-kit-positive TC sub-
population seems to almost completely disappear in human corneas
affected by keratoconus, a degenerative corneal ectasia which results
in progressive thinning of the cornea and, in more advanced stages,
stromal scarring potentially leading to a severe visual impairment and
to the necessity of corneal transplantation [6, 7, 9]. Therefore, the
depletion of c-kit-positive TC might contribute to the progression of
such a corneal degenerative process by hampering local reparative
mechanisms during keratoconus.
It is commonly believed that TC may play an important role in
driving organ development and contributing to the maintenance of
local tissue homoeostasis and, hence, TC damage and dysfunction
may occur in several disorders [23–33, 52, 53]. In this context, we
herein demonstrate that the normal morphological features and distri-
bution of TC are severely compromised within the corneal stromal
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Fig. 3 Representative light and fluorescence microscopy photomicrographs of normal and keratoconic human corneal sections. (A and B) CD34
immunoperoxidase-based immunohistochemistry with haematoxylin counterstain. (A) In control normal corneas, CD34-positive stromal cells display-
ing morphological features of telocytes are orderly arranged and parallel to the corneal surface. (B) In keratoconus, a patchy loss of CD34-positive
stromal cells is mostly evident in the anterior corneal stroma. Insets: Higher magnification views of CD34-positive corneal stromal cells. (C) Results
of quantitative analysis of CD34-positive telocyte counts per high-power field in the corneal stroma of healthy controls (n = 6) and patients with ker-
atoconus (n = 6). Data are mean  S.D. *P < 0.001 versus control. (D–I) Double immunofluorescence labelling for CD34 (red) and PDGFRa
(green) with DAPI (blue) counterstain for nuclei. (D–F) In control normal corneas, CD34+/PDGFRa+ stromal cells (telocytes) are orderly distributed
throughout the stromal compartment. (G–I) In keratoconic corneas, a patchy loss of CD34+/PDGFRa+ stromal cells (telocytes) is mainly evident in
the subepithelial stroma. (J and K) Double immunofluorescence labelling for CD34 (red) and c-kit (green) with DAPI (blue) counterstain for nuclei.
(J) In control normal corneas, numerous CD34+/c-kit+ stromal cells (telocytes) are present throughout the stromal layer. (K) In keratoconic corneas,
the CD34+/c-kit+ stromal cell subpopulation is almost completely lost. (L) Results of quantitative analysis of c-kit-positive telocyte counts per high-
power field in the corneal stroma of healthy controls (n = 6) and patients with keratoconus (n = 6). Data are mean  S.D. *P < 0.001 versus con-
trol. TC: telocytes; hpf: high-power field. Scale bar: 100 lm (A and B), 50 lm (D–K).
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compartment in keratoconic pathology. Indeed, keratoconic corneas
were characterized by a severe reduction in TC mainly in the anterior
stroma and, at the ultrastructural level, most of the remaining TC
displayed degenerative features including numerous swollen mito-
chondria, loss of organelles, cytoplasmic vacuolization, shrinkage and




Fig. 4 Representative transmission electron microscopy photomicrographs of normal and keratoconic human corneal ultrathin sections. (A) In nor-
mal human corneas, the typical ultrastructural morphology of telocytes and telopodes is observed. (B and C) In keratoconic corneas, telocytes dis-
play ultrastructural abnormalities including numerous swollen mitochondria, loss of organelles and cytoplasmic vacuolization. Inset: Higher
magnification of damaged mitochondria. (D) In keratoconus, some telocytes and telopodes display a preserved ultrastructural morphology. Note the
typical moniliform aspect of telopodes with the alternation of podoms and podomers. (E) Shrinkage and shortening of the telopodes along with
apoptotic chromatin condensation and nuclear fragmentation are evident in a telocyte from keratoconic corneal stroma. TC: telocyte; Tp: telopode.
Scale bar: 2 lm (A and E), 5 lm (B–D).
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condensation and nuclear fragmentation. Of note, these observations
are in agreement with previous studies describing an increase in the
apoptotic rate within the keratoconic corneal stroma as detected by
TUNEL assay [6, 7]. According to the possible functions which have
been proposed for TC in a variety of organs [11, 12, 46], the regular
distribution of TC and their telopodes that we observed throughout
the whole normal corneal stroma might contribute to the correct
assembly and maintenance of a highly organized collagenous matrix
which is essential for conferring the adequate corneal transparency
and mechanical stability. In addition, we found that in the normal cor-
nea, TC establish homocellular contacts formed by gap junctions,
highly specialized membrane structures which allow the exchange of
small molecular mediators involved in intercellular signalling and thus
contributing to the maintenance of tissue homoeostasis [38, 39]. As
suggested in other pathologies [23, 25–29], the reduction and loss of
TC might therefore contribute to the altered organization of the ECM
ultimately resulting into corneal dysfunction in keratoconus.
In conclusion, our data provide the first demonstration that TC are
present in the human cornea and also highlight their possible
implication in corneal pathology. Further in vitro and in vivo studies
are warranted to clarify the biological functions of TC in corneal repair
and regeneration. In particular, deciphering the differential roles of
corneal TC subtypes might provide new insights into their possible
therapeutic utility in the context of corneal regenerative medicine.
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